[The effect of the beta-blockers nadolol and metipranolol in patients with thyrotoxicosis].
Vavrejnová
V
V
Felt
V
V
Nedvídková
J
J
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy* / Q000503:physiopathology; D014290:Metipranolol / Q000627:therapeutic use*; D008875:Middle Aged; D009248:Nadolol; D011412:Propanolamines / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D009248:Nadolol; D014290:Metipranolol
Ucinky beta-blokátorů nadololu a metipranolu u nemocných s tyreotoxikózou.